NEW HAVEN, Conn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in direct DNA modification developing novel cancer therapeutics, has been selected by the National Cancer Institute ...
NEW HAVEN, Conn., July 28, 2022 -- Modifi Biosciences announced today that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of ...
NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in DNA modification as a novel approach to target cancer, today announced the closing of $4.3 million in a second round ...
Dr. Ranjit Bindra of Modifi Bio speaks at the ribbon-cutting of the Elm City Bioscience Center in New Haven on Sept. 14, 2022. PHOTO LIESE KLEIN The National Cancer Institute is awarding a $2.4 ...
Modifi Biosciences announced today that the journal Science has published a critical study validating the company's novel oncology platform based on new classes of molecules that exploit ...
Modifi Biosciences founders, from left: Kingson Lin, Soros Fellow at Yale University; Kevin Rakin, partner at HighCape Capital; Seth Herzon, Milton Harris Professor of chemistry and pharmacology at ...
Modifi Biosciences Inc. has come a long way very quickly. Spun out of Yale University in 2021, it published data on DNA in Science in July 2022, and now it’s being acquired by Merck & Co. Inc. for $30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback